drugset / Trial / NCT05760248

Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity

NCT05760248

Phase 2 Completed 13 enrolled 10xBio, LLC Therapeutics, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to test the safety and effectiveness of an injection study drug in decreasing bilateral flank adiposity. The main question it aims to answer is: •How safe and effective is the injection study drug in removing bilateral flank adiposity compared to a placebo? Participants will be: * Be given injections every month for 5 months over the right and left flanks. * Be asked to be seen in the clinic for 13 visits and 3 phone call visits during a duration of 1 year.

Timeline

Start
2023-05-04
Primary completion
2025-01-22
Completion
2025-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Polidocanol Other / unclassified 6 % Subcutaneous